image
Healthcare - Medical - Devices - NYSE - US
$ 133.18
-1.22 %
$ 4.47 B
Market Cap
40.85
P/E
1. INTRINSIC VALUE

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles.[ Read More ]

The intrinsic value of one ITGR stock under the base case scenario is HIDDEN Compared to the current market price of 133 USD, Integer Holdings Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ITGR

image
FINANCIALS
1.6 B REVENUE
16.03%
167 M OPERATING INCOME
37.92%
90.6 M NET INCOME
36.57%
180 M OPERATING CASH FLOW
54.85%
-163 M INVESTING CASH FLOW
18.49%
-18 M FINANCING CASH FLOW
-19.48%
746 M REVENUE
70.94%
58 M OPERATING INCOME
-4.43%
35.4 M NET INCOME
13.42%
71.5 M OPERATING CASH FLOW
51.37%
-26.2 M INVESTING CASH FLOW
14.26%
-43.1 M FINANCING CASH FLOW
-75.91%
Balance Sheet Decomposition Integer Holdings Corporation
image
Current Assets 618 M
Cash & Short-Term Investments 23.7 M
Receivables 326 M
Other Current Assets 268 M
Non-Current Assets 2.32 B
Long-Term Investments 11.8 M
PP&E 501 M
Other Non-Current Assets 1.81 B
Current Liabilities 221 M
Accounts Payable 120 M
Short-Term Debt 10.6 M
Other Current Liabilities 90.1 M
Non-Current Liabilities 1.2 B
Long-Term Debt 1.04 B
Other Non-Current Liabilities 160 M
EFFICIENCY
Earnings Waterfall Integer Holdings Corporation
image
Revenue 1.6 B
Cost Of Revenue 1.18 B
Gross Profit 418 M
Operating Expenses 251 M
Operating Income 167 M
Other Expenses 76.7 M
Net Income 90.6 M
RATIOS
26.20% GROSS MARGIN
26.20%
10.48% OPERATING MARGIN
10.48%
5.68% NET MARGIN
5.68%
5.97% ROE
5.97%
3.08% ROA
3.08%
5.70% ROIC
5.70%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Integer Holdings Corporation
image
Net Income 90.6 M
Depreciation & Amortization 98.8 M
Capital Expenditures -120 M
Stock-Based Compensation 23.3 M
Change in Working Capital -52.3 M
Others 28.7 M
Free Cash Flow 60.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Integer Holdings Corporation
image
Wall Street analysts predict an average 1-year price target for ITGR of $138 , with forecasts ranging from a low of $125 to a high of $145 .
ITGR Lowest Price Target Wall Street Target
125 USD -6.14%
ITGR Average Price Target Wall Street Target
138 USD 3.43%
ITGR Highest Price Target Wall Street Target
145 USD 8.88%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Integer Holdings Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
3.77 M USD 4
6-9 MONTHS
1.76 M USD 4
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Jul 31, 2024
Sell 1.24 M USD
Hobby Jean M.
Director
- 10328
119.5891 USD
3 months ago
Jul 31, 2024
Sell 196 K USD
Hobby Jean M.
Director
- 1632
120.1078 USD
3 months ago
Jul 31, 2024
Sell 559 K USD
MAXWELL MARTIN C
Director
- 4700
118.8775 USD
3 months ago
Jul 30, 2024
Sell 421 K USD
Harris John A
EVP, Global Ops and Manufactur
- 3400
123.8 USD
5 months ago
Jun 04, 2024
Sell 183 K USD
Harris John A
EVP, Global Ops and Manufactur
- 1521
120.435 USD
5 months ago
May 24, 2024
Sell 1.18 M USD
Hinrichs James F.
Director
- 9603
122.438 USD
6 months ago
May 10, 2024
Sell 992 K USD
Khales Payman
President, C&V
- 8712
113.836 USD
6 months ago
May 07, 2024
Sell 35.3 K USD
Harris John A
EVP, Global Ops and Manufactur
- 312
113 USD
6 months ago
May 07, 2024
Sell 531 K USD
Senn Andrew
SVP, Strategy and Business Dev
- 4700
113.084 USD
6 months ago
May 07, 2024
Sell 34.2 K USD
Senn Andrew
SVP, Strategy and Business Dev
- 300
114.043 USD
6 months ago
Apr 30, 2024
Sell 171 K USD
Thomas Tommy P
VP, Corporate Controller
- 1500
114 USD
1 year ago
Sep 11, 2023
Sell 99.6 K USD
Spence Donald J
Director
- 1206
82.55 USD
1 year ago
Sep 11, 2023
Sell 436 K USD
Spence Donald J
Director
- 5294
82.264 USD
1 year ago
Jun 09, 2023
Sell 304 K USD
Hobby Jean M.
Director
- 3625
83.85 USD
1 year ago
Dec 31, 2022
Bought 0 USD
Dziedzic Joseph W
President & CEO
+ 5206
0 USD
1 year ago
Dec 16, 2022
Bought 248 K USD
Dziedzic Joseph W
President & CEO
+ 4000
61.9476 USD
1 year ago
Dec 01, 2022
Sell 520 K USD
BAILEY PAMELA G
Director
- 7018
74.059 USD
1 year ago
Nov 30, 2022
Sell 71.2 K USD
Bolt Jennifer M
EVP, Global Operations & ESG
- 1000
71.16 USD
2 years ago
Aug 12, 2022
Sell 201 K USD
Houghton Carter
President, Electrochem
- 2708
74.127 USD
2 years ago
Mar 02, 2022
Sell 254 K USD
Hobby Jean M.
director:
- 3125
81.26 USD
2 years ago
Jan 22, 2022
Bought 47.6 K USD
Thomas Tommy P
VP, Corporate Controller
+ 597
79.76 USD
2 years ago
Dec 07, 2021
Sell 102 K USD
Hobby Jean M.
Director
- 1200
85.383 USD
2 years ago
Dec 06, 2021
Sell 594 K USD
BAILEY PAMELA G
Director
- 7031
84.503 USD
2 years ago
Dec 06, 2021
Sell 17 K USD
BAILEY PAMELA G
Director
- 200
85.072 USD
3 years ago
Sep 14, 2021
Sell 246 K USD
Flanagan Joseph F
EVP, Quality & Regulatory Affa
- 2645
93.131 USD
3 years ago
Aug 20, 2021
Sell 976 K USD
SANFORD BILL R
Director
- 10104
96.603 USD
3 years ago
Aug 20, 2021
Sell 41.1 K USD
SANFORD BILL R
Director
- 423
97.21 USD
3 years ago
Aug 11, 2021
Sell 99.2 K USD
Borowicz Anthony W
SVP Strategy,Corp Dev., IR
- 1100
90.22 USD
3 years ago
Aug 04, 2021
Sell 234 K USD
Houghton Carter
President, Electrochem
- 2500
93.547 USD
3 years ago
Jun 15, 2021
Sell 990 K USD
SANFORD BILL R
Director
- 10846
91.2451 USD
3 years ago
Mar 12, 2021
Sell 199 K USD
Hobby Jean M.
Director
- 2100
94.947 USD
3 years ago
Feb 23, 2021
Sell 113 K USD
Borowicz Anthony W
SVP Strategy,Corp Dev., IR
- 1337
84.747 USD
3 years ago
Dec 31, 2020
Bought 0 USD
Giddens Elizabeth
SVP, General Counsel
+ 326
0 USD
4 years ago
Nov 16, 2020
Sell 443 K USD
BAILEY PAMELA G
Director
- 6217
71.1849 USD
4 years ago
Nov 05, 2020
Bought 291 K USD
Dziedzic Joseph W
President & CEO
+ 5000
58.122 USD
4 years ago
Aug 20, 2020
Sell 651 K USD
SANFORD BILL R
Director
- 9300
70.005 USD
4 years ago
Aug 21, 2020
Sell 1.75 K USD
SANFORD BILL R
Director
- 26
67.26 USD
4 years ago
Aug 10, 2020
Bought 52.5 K USD
Dziedzic Joseph W
President & CEO
+ 800
65.625 USD
4 years ago
Aug 07, 2020
Bought 155 K USD
Dziedzic Joseph W
President & CEO
+ 2400
64.6746 USD
4 years ago
Jun 08, 2020
Sell 452 K USD
Flanagan Joseph F
EVP, Quality & Regulatory Affa
- 5308
85.18 USD
4 years ago
Mar 03, 2020
Sell 270 K USD
SUMMERS WILLIAM B JR
Director
- 3022
89.41 USD
4 years ago
Mar 03, 2020
Sell 27.1 K USD
SUMMERS WILLIAM B JR
Director
- 300
90.23 USD
4 years ago
Mar 03, 2020
Sell 974 K USD
SUMMERS WILLIAM B JR
Director
- 11235
86.69 USD
4 years ago
Mar 03, 2020
Sell 500 K USD
SUMMERS WILLIAM B JR
Director
- 5725
87.37 USD
7. News
Here's Why Integer (ITGR) is a Strong Growth Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 2 days ago
Integer to Present at Piper Sandler Healthcare Conference on Dec. 3, 2024 PLANO, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), will participate in the Piper Sandler 36th Annual Healthcare Conference, to be held Dec. 3 – 5 in New York City. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present Tuesday, Dec. 3, 2024, at 10:30 a.m. EST. globenewswire.com - 2 days ago
Integer Holdings Gains 40.8% YTD: What's Driving the Stock? ITGR shares gain on the back of growth in the Medical segment. However, fluctuations in the oil and energy market are concerning. zacks.com - 4 days ago
Integer Holdings Corporation Completes Divestiture of Non-Medical Business for $50 Million Electrochem divestiture makes Integer a pure-play medical technology company Electrochem divestiture makes Integer a pure-play medical technology company globenewswire.com - 2 weeks ago
Here's Why Integer (ITGR) is a Strong Growth Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 2 weeks ago
Integer Holdings Q3 Earnings Surpass Estimates, Revenues Up Y/Y ITGR's third-quarter results reflect solid Medical sales and margin expansion amid the divestiture of its Electrochem business. zacks.com - 3 weeks ago
Integer Holdings Corporation (ITGR) Q3 2024 Earnings Call Transcript Integer Holdings Corporation (NYSE:ITGR ) Q3 2024 Earnings Call Transcript October 24, 2024 9:00 AM ET Company Participants Andrew Senn - SVP of Strategy, Business Development and IR Joe Dziedzic - President and CEO Diron Smith - EVP and CFO Conference Call Participants Brett Fishbin - KeyBanc Craig Bijou - Bank of America Rich Newitter - Truist Securities Joanne Wuensch - Citi Matthew O'Brien - Piper Sandler Kristen Stewart - CL King Suraj Kalia - Oppenheimer Operator Hello, and welcome to the Integer Holdings Corporation Third Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise. seekingalpha.com - 3 weeks ago
Integer (ITGR) Reports Q3 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Integer (ITGR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 3 weeks ago
Integer (ITGR) Q3 Earnings Surpass Estimates Integer (ITGR) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.27 per share a year ago. zacks.com - 3 weeks ago
Unlocking Q3 Potential of Integer (ITGR): Exploring Wall Street Estimates for Key Metrics Evaluate the expected performance of Integer (ITGR) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com - 3 weeks ago
Integer (ITGR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 month ago
Integer Holdings (ITGR) Gains 30.5% YTD: What's Driving the Stock? Integer Holdings (ITGR) shares gain on the back of growth in the Medical segment. However, fluctuations in raw material prices and the oil and energy market are concerning. zacks.com - 1 month ago
8. Profile Summary

Integer Holdings Corporation ITGR

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 4.47 B
Dividend Yield 0.00%
Description Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Contact 5830 Granite Parkway, Plano, TX, 75024 https://www.integer.net
IPO Date Sept. 29, 2000
Employees 10500
Officers Mr. Diron Smith Executive Vice President & Chief Financial Officer Mr. Payman Khales President of Cardio & Vascular Mr. Andrew Senn Senior Vice President of Strategy, Business Development & Investor Relations Mr. Jim Stephens President of Cardiac Rhythm Management & Neuromodulation Mr. Tom P. Thomas Vice President, Corporate Controller & Principal Accounting Officer Ms. Margaret Carthy Executive Vice President of Global Quality & Regulatory Affairs Mr. John Harris Executive Vice President of Global Operations & Manufacturing Strategy Mr. Joseph W. Dziedzic President, Chief Executive Officer & Director Mr. McAlister C. Marshall II Senior Vice President, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary